Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations

Kara Grimes,1,* Chisom T Madu,2 Carena Carrington,3 Daniel Laroche4,5,* 1School of Medicine, New York Medical College, Valhalla, NY, USA; 2School of Medicine, City University of New York School of Medicine, New Yorkṭ, NY, USA; 3School of Medicine, SUNY Downstate Health Sciences Unive...

Full description

Saved in:
Bibliographic Details
Main Authors: Grimes K, Madu CT, Carrington C, Laroche D
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/validation-of-a-novel-low-cost-glaucoma-risk-calculator-for-community--peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540606230953984
author Grimes K
Madu CT
Carrington C
Laroche D
author_facet Grimes K
Madu CT
Carrington C
Laroche D
author_sort Grimes K
collection DOAJ
description Kara Grimes,1,* Chisom T Madu,2 Carena Carrington,3 Daniel Laroche4,5,* 1School of Medicine, New York Medical College, Valhalla, NY, USA; 2School of Medicine, City University of New York School of Medicine, New Yorkṭ, NY, USA; 3School of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA; 4Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA; 5Advanced Eye Care of New York, New York, NY, USA*These authors contributed equally to this workCorrespondence: Daniel Laroche, Advanced Eye Care of New York, 49 West 127th Street, New York, NY, 10027, USA, Tel +1-212-663-0473, Email dlarochemd@aol.comPurpose: To assess the validity of a novel, low-cost glaucoma screening calculator in determining glaucoma risk in high-risk New York communities.Patients and Methods: This prognostic community-based study was conducted in New York City neighborhoods from 2022 to 2024 among participants aged 40 years and older. Glaucoma screenings were held at community gatherings including local fairs, senior citizen homes, places of worship, and in the lobby of medical offices. The screenings were conducted by trained non-physician medical personnel comprised medical students and medical assistants working under physician supervision. Participants’ intraocular pressure (IOP) and central corneal thickness (CCT) were measured in both eyes with a handheld tonometer and pachymeter, respectively. Participants then completed a comprehensive eye exam by an ophthalmologist to confirm glaucoma status. Statistical analysis was completed using MedCalc version 22.023 (MedCalc Software Ltd. Ostend, Belgium) with 95% confidence intervals.Results: Of the 823 study participants, 716 (mean age 62.9 ± 11.9 years) were eligible to participate and completed the comprehensive follow-up exam. 68% identified as Black, 6.7% identified as Hispanic/Latino, and 52.5% identified as female. The Laroche glaucoma calculator had a sensitivity of 93.5% (CI 89.1– 96.5%), specificity of 91.3% (CI 88.5– 93.6%), positive predictive value of 80.5% (CI 75.7– 84.6%), negative predictive value of 97.3% (CI 95.5– 98.4%) and accuracy of 91.9% (CI 89.6– 93.8%).Conclusion: The Laroche glaucoma calculator shows high sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using affordable screening methods to determine glaucoma risk.Keywords: glaucoma risk calculator, affordable glaucoma screening, glaucoma screening tools, community-based glaucoma study, Laroche glaucoma calculator, eye screening
format Article
id doaj-art-74eca358765e4d1485956d19edd5ce4f
institution Kabale University
issn 1177-5483
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj-art-74eca358765e4d1485956d19edd5ce4f2025-02-04T17:15:41ZengDove Medical PressClinical Ophthalmology1177-54832025-02-01Volume 1935736999838Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk PopulationsGrimes KMadu CTCarrington CLaroche DKara Grimes,1,* Chisom T Madu,2 Carena Carrington,3 Daniel Laroche4,5,* 1School of Medicine, New York Medical College, Valhalla, NY, USA; 2School of Medicine, City University of New York School of Medicine, New Yorkṭ, NY, USA; 3School of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA; 4Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA; 5Advanced Eye Care of New York, New York, NY, USA*These authors contributed equally to this workCorrespondence: Daniel Laroche, Advanced Eye Care of New York, 49 West 127th Street, New York, NY, 10027, USA, Tel +1-212-663-0473, Email dlarochemd@aol.comPurpose: To assess the validity of a novel, low-cost glaucoma screening calculator in determining glaucoma risk in high-risk New York communities.Patients and Methods: This prognostic community-based study was conducted in New York City neighborhoods from 2022 to 2024 among participants aged 40 years and older. Glaucoma screenings were held at community gatherings including local fairs, senior citizen homes, places of worship, and in the lobby of medical offices. The screenings were conducted by trained non-physician medical personnel comprised medical students and medical assistants working under physician supervision. Participants’ intraocular pressure (IOP) and central corneal thickness (CCT) were measured in both eyes with a handheld tonometer and pachymeter, respectively. Participants then completed a comprehensive eye exam by an ophthalmologist to confirm glaucoma status. Statistical analysis was completed using MedCalc version 22.023 (MedCalc Software Ltd. Ostend, Belgium) with 95% confidence intervals.Results: Of the 823 study participants, 716 (mean age 62.9 ± 11.9 years) were eligible to participate and completed the comprehensive follow-up exam. 68% identified as Black, 6.7% identified as Hispanic/Latino, and 52.5% identified as female. The Laroche glaucoma calculator had a sensitivity of 93.5% (CI 89.1– 96.5%), specificity of 91.3% (CI 88.5– 93.6%), positive predictive value of 80.5% (CI 75.7– 84.6%), negative predictive value of 97.3% (CI 95.5– 98.4%) and accuracy of 91.9% (CI 89.6– 93.8%).Conclusion: The Laroche glaucoma calculator shows high sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using affordable screening methods to determine glaucoma risk.Keywords: glaucoma risk calculator, affordable glaucoma screening, glaucoma screening tools, community-based glaucoma study, Laroche glaucoma calculator, eye screeninghttps://www.dovepress.com/validation-of-a-novel-low-cost-glaucoma-risk-calculator-for-community--peer-reviewed-fulltext-article-OPTHglaucoma risk calculatoraffordable glaucoma screeningglaucoma screening toolscommunity-based glaucoma studylaroche glaucoma calculatoreye screening
spellingShingle Grimes K
Madu CT
Carrington C
Laroche D
Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
Clinical Ophthalmology
glaucoma risk calculator
affordable glaucoma screening
glaucoma screening tools
community-based glaucoma study
laroche glaucoma calculator
eye screening
title Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
title_full Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
title_fullStr Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
title_full_unstemmed Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
title_short Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations
title_sort validation of a novel low cost glaucoma risk calculator for community based screening in high risk populations
topic glaucoma risk calculator
affordable glaucoma screening
glaucoma screening tools
community-based glaucoma study
laroche glaucoma calculator
eye screening
url https://www.dovepress.com/validation-of-a-novel-low-cost-glaucoma-risk-calculator-for-community--peer-reviewed-fulltext-article-OPTH
work_keys_str_mv AT grimesk validationofanovellowcostglaucomariskcalculatorforcommunitybasedscreeninginhighriskpopulations
AT maduct validationofanovellowcostglaucomariskcalculatorforcommunitybasedscreeninginhighriskpopulations
AT carringtonc validationofanovellowcostglaucomariskcalculatorforcommunitybasedscreeninginhighriskpopulations
AT laroched validationofanovellowcostglaucomariskcalculatorforcommunitybasedscreeninginhighriskpopulations